Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma
Abstract Oncogenic drivers of progression of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) such as c-MYC have downstream effects on intracellular metabolic pathways of clonal plasma cells (PCs). Thus, extracellular environments such as the bone marrow (BM) plasma...
Enregistré dans:
Auteurs principaux: | Wilson I. Gonsalves, Katarzyna Broniowska, Erik Jessen, Xuan-Mai Petterson, Alexander Graham Bush, Jaimee Gransee, Martha Q. Lacy, Taro Hitosugi, Shaji K. Kumar |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/be1ea48f80f147afb852802099cac5d1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Coexistence of Prefibrotic Myelofibrosis with Monoclonal Gammopathy of Undetermined Significance: A Case Report
par: Omar M. Ismail, et autres
Publié: (2021) -
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
par: Saemundur Rognvaldsson, et autres
Publié: (2021) -
Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study
par: Nicola Hornung, et autres
Publié: (2021) -
A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea
par: Ka-Won Kang, et autres
Publié: (2021) -
Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters
par: Pasiarski M, et autres
Publié: (2019)